UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The diagnosis and management of congenital hemophilia

Seminars in thrombosis and hemostasis, 2012-10, Vol.38 (7), p.727-734

Carcao, Manuel D

2012

Volltextzugriff (PDF)

Professor Victor S. Blanchette, MA, MB, BChir (Cantab), FRCP(C), FRCP (1945-2024)

Journal of thrombosis and haemostasis, 2024-09

2024

Volltextzugriff (PDF)

Individualizing factor replacement therapy in severe hemophilia

Seminars in thrombosis and hemostasis, 2015-11, Vol.41 (8), p.864-871

2015

Volltextzugriff (PDF)

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Blood, 2019-09, Vol.134 (11), p.880-891

2019

Volltextzugriff (PDF)

Rare case of refractory mixed autoimmune hemolytic anemia in a 6-year-old child: a case report

Journal of medical case reports, 2023-10, Vol.17 (1), p.1-418, Article 418

2023

Volltextzugriff (PDF)

Hemophilia in a Changing Treatment Landscape

Hematology/oncology clinics of North America, 2019-06, Vol.33 (3), p.409-423

2019

Volltextzugriff (PDF)

Genotype–phenotype correlation in children with hereditary spherocytosis

British journal of haematology, 2020-11, Vol.191 (3), p.486-496

2020

Volltextzugriff (PDF)

NBEAL2 mutations and bleeding in patients with gray platelet syndrome

Platelets (Edinburgh), 2018-08, Vol.29 (6), p.632-635

2018

Volltextzugriff (PDF)

Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.116-122

2024

Volltextzugriff (PDF)

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

Blood, 2012-05, Vol.119 (22), p.5111-5117

2012

Volltextzugriff (PDF)

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Journal of thrombosis and haemostasis, 2019-07, Vol.17 (7), p.1085-1096

2019

Volltextzugriff (PDF)

Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis

British journal of haematology, 2023-05, Vol.201 (4), p.e46-e49

2023

Volltextzugriff (PDF)

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

Thrombosis and haemostasis, 2021-10, Vol.121 (10), p.1326-1336

2021

Volltextzugriff (PDF)

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-11, Vol.29 (6), p.1638-1645

2023

Volltextzugriff (PDF)

Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels

Thrombosis and haemostasis, 2016, Vol.115 (5), p.913-920

2016

Volltextzugriff (PDF)

Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha‐2‐antiplasmin deficiency

British journal of haematology, 2019-09, Vol.186 (6), p.e198-e201

2019

Volltextzugriff (PDF)

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

Haematologica (Roma), 2015-03, Vol.100 (3), p.e84-e86

2015

Volltextzugriff (PDF)

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A

Blood, 2013-05, Vol.121 (19), p.3946-3952

2013

Volltextzugriff (PDF)

Dieulafoy lesions and PHACE syndrome

Pediatric dermatology, 2019-11, Vol.36 (6), p.902-905

2019

Volltextzugriff (PDF)

Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions

British journal of haematology, 2018-05, Vol.181 (3), p.410-413

2018

Volltextzugriff (PDF)

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children

British journal of haematology, 2018-10, Vol.183 (2), p.267-275

2018

Volltextzugriff (PDF)

Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon

Pediatric blood & cancer, 2012-11, Vol.59 (5), p.934-938

2012

Volltextzugriff (PDF)

Vincristine for successful treatment of steroid-dependent infantile hemangiomas

Pediatrics (Evanston), 2015-06, Vol.135 (6), p.e1501-e1505

2015

Volltextzugriff (PDF)

The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study

Therapeutic advances in hematology, 2024-01, Vol.15, p.20406207231218624-20406207231218624

2024

Volltextzugriff (PDF)

Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A

American journal of hematology, 2017-06, Vol.92 (6), p.E94-E96

2017

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Englisch
(201)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The diagnosis and management of congenital hemophilia

Professor Victor S. Blanchette, MA, MB, BChir (Cantab), FRCP(C), FRCP (1945-2024)

Individualizing factor replacement therapy in severe hemophilia

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Rare case of refractory mixed autoimmune hemolytic anemia in a 6-year-old child: a case report

Hemophilia in a Changing Treatment Landscape

Genotype–phenotype correlation in children with hereditary spherocytosis

NBEAL2 mutations and bleeding in patients with gray platelet syndrome

Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis

A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13

Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels

Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha‐2‐antiplasmin deficiency

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A

Dieulafoy lesions and PHACE syndrome

Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children

Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon

Vincristine for successful treatment of steroid-dependent infantile hemangiomas

The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study

Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A

Suchergebnisse filtern